Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Prof Gordon McVie provides highlights from ecancer for October 2016:
Firstline pembrolizumab for metastatic urothelial cancer, news story here
Promising results in metastatic bladder cancer using immunotherapy
Niraparib significantly improves outcomes for ovarian cancer patients, news story here
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Phosphoethanolamine and the danger of unproven drugs
Breast cancer surgery course for post-graduate surgical trainees